These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
869 related articles for article (PubMed ID: 31445768)
21. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
22. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer. Azghadi S; Daly M; Mayadev J Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803 [TBL] [Abstract][Full Text] [Related]
23. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era. Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702 [TBL] [Abstract][Full Text] [Related]
24. The intraoperative assessment of sentinel nodes - Standards and controversies. van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534 [TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Reitsamer R; Peintinger F; Rettenbacher L; Prokop E J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778 [TBL] [Abstract][Full Text] [Related]
26. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms? Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V Tumori; 2015; 101(3):298-305. PubMed ID: 25838248 [TBL] [Abstract][Full Text] [Related]
27. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379 [TBL] [Abstract][Full Text] [Related]
28. Contemporary management of the axilla in breast cancer. Nurudeen S; Hunt KK Clin Adv Hematol Oncol; 2018 Dec; 16(12):823-831. PubMed ID: 30843891 [TBL] [Abstract][Full Text] [Related]
29. Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network. Ghilli M; Becherini C; Meattini I; Angiolini C; Bengala C; Marconi A; Galli L; Angiolucci G; Coltelli L; Borghesi S; Lastrucci L; Manca G; Bianchi S; Doria M; Casella D; Marotti L; Amunni G; Roncella M Radiol Med; 2024 Jun; 129(6):945-954. PubMed ID: 38683499 [TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer. Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680 [TBL] [Abstract][Full Text] [Related]
31. Predictors of positive axillary non-sentinel lymph nodes in breast cancer patients with positive sentinel lymph node biopsy after neoadjuvant systemic therapy. Leonardi MC; Arrobbio C; Gandini S; Volpe S; Colombo F; La Rocca E; Galimberti V; Kahler-Ribeiro-Fontana S; Fodor C; Dicuonzo S; Rojas DP; Zerella MA; Morra A; Montagna E; Colleoni M; Mazzarol G; Travaini LL; Zaffaroni M; Veronesi P; Orecchia R; Jereczek-Fossa BA Radiother Oncol; 2021 Oct; 163():128-135. PubMed ID: 34461184 [TBL] [Abstract][Full Text] [Related]
32. Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice. Gera R; Kasem A; Mokbel K In Vivo; 2018; 32(6):1301-1307. PubMed ID: 30348682 [TBL] [Abstract][Full Text] [Related]
33. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients? Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380 [TBL] [Abstract][Full Text] [Related]
34. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative). Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784 [TBL] [Abstract][Full Text] [Related]
35. Repeat surgery following breast conservation and intra-operative sentinel lymph node analysis for breast cancer. Dabbas N; Cutress RI; Wise M; Yiangou C; Agrawal A Surgeon; 2013 Oct; 11(5):235-40. PubMed ID: 23453370 [TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. Gherghe M; Bordea C; Blidaru A J Med Life; 2015; 8(2):176-80. PubMed ID: 25866575 [TBL] [Abstract][Full Text] [Related]
37. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona. Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141 [TBL] [Abstract][Full Text] [Related]